SeaCrest Wealth Management’s Armata Pharmaceuticals ARMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66.4K | Hold |
34,954
| – | – | 0.01% | 611 |
|
|
2025
Q1 | $51K | Hold |
34,954
| – | – | 0.01% | 650 |
|
|
2024
Q4 | $64.7K | Hold |
34,954
| – | – | 0.01% | 645 |
|
|
2024
Q3 | $82.8K | Hold |
34,954
| – | – | 0.01% | 639 |
|
|
2024
Q2 | $96.1K | Buy |
34,954
+2,177
| +7% | +$5.99K | 0.01% | 599 |
|
|
2024
Q1 | $137K | Buy |
32,777
+14,647
| +81% | +$61.2K | 0.02% | 583 |
|
|
2023
Q4 | $56.4K | Hold |
18,130
| – | – | 0.01% | 611 |
|
|
2023
Q3 | $54.4K | Hold |
18,130
| – | – | 0.01% | 611 |
|
|
2023
Q2 | $20.7K | Hold |
18,130
| – | – | ﹤0.01% | 624 |
|
|
2023
Q1 | $30.3K | Hold |
18,130
| – | – | ﹤0.01% | 624 |
|
|
2022
Q4 | $22.5K | Buy |
18,130
+580
| +3% | +$719 | ﹤0.01% | 629 |
|
|
2022
Q3 | $74K | Hold |
17,550
| – | – | 0.01% | 605 |
|
|
2022
Q2 | $68K | Buy |
17,550
+850
| +5% | +$3.29K | 0.01% | 998 |
|
|
2022
Q1 | $82K | Buy |
16,700
+3,200
| +24% | +$15.7K | 0.01% | 697 |
|
|
2021
Q4 | $74K | Hold |
13,500
| – | – | 0.01% | 695 |
|
|
2021
Q3 | $49K | Hold |
13,500
| – | – | 0.01% | 671 |
|
|
2021
Q2 | $54K | Hold |
13,500
| – | – | 0.01% | 685 |
|
|
2021
Q1 | $65K | Buy |
13,500
+845
| +7% | +$4.07K | 0.01% | 652 |
|
|
2020
Q4 | $38K | Hold |
12,655
| – | – | 0.01% | 618 |
|
|
2020
Q3 | $40K | Hold |
12,655
| – | – | 0.01% | 575 |
|
|
2020
Q2 | $50K | Hold |
12,655
| – | – | 0.01% | 545 |
|
|
2020
Q1 | $39K | Buy |
+12,655
| New | +$39K | 0.01% | 501 |
|